Aktuell 21 nov 2023 CRISPR Therapeutics und Vertex erhalten historische Zulassung Die Partner CRISPR Therapeutics und Vertex haben in Grossbritannien die weltweit erste Zulassung einer Therapie erreicht, die auf Genom-Editie...
Branchenreport 02 out 2023 Cybersicherheitsökosysteme in Grossbritannien und Irland – ein Leitfaden für die Schweizer Branche In einer zunehmend digitalen Welt ist Cybersicherheit über Grenzen und Branchen hinweg von grösster Bedeutung. Im Fokus dieser Studie steht die g...
Rapport sectoriel 02 out 2023 Cybersécurité au Royaume-Uni et en Irlande: guide pour sociétés suisses Dans un monde toujours plus numérisé, la cybersécurité est amenée à jouer un rôle crucial sur le marché, transcendant les frontières et les secte...
Rapporti settoriali 02 out 2023 Cybersecurity nel Regno Unito e in Irlanda: una guida per le aziende svizzere In un mondo sempre più digitalizzato, la sicurezza informatica è destinata a svolgere un ruolo cruciale nel mercato, superando confini e settori ...
News 21 nov 2023 CRISPR Therapeutics and Vertex awarded historic authorization The two partners CRISPR Therapeutics and Vertex have secured the world’s first approval for a genome editing therapy based on what are known as g...
Industry Report 02 out 2023 Cyber Security Ecosystems in UK and Ireland - a guide for the Swiss Industry In an increasingly digital world, cybersecurity is of paramount importance, transcending borders and industries. This study focuses on the global...
News 12 jun 2023 Lonza boosts next-generation anticancer drugs with CHF 97 million investment in Visp Pharma giant Lonza is enhancing its capabilities in the development of novel cancer treatments through an investment of over CHF 97 million in Vi...
News 11 abr 2023 PeriVision and Swistor each receive a CHF 100,000 FIT Tech Seed loan Two innovative start-ups from the canton of Vaud, PeriVision and Swistor, have each received a Tech Seed loan from the FIT to support their devel...
News 22 jan 2024 Supercomputers help to reduce inequality The Federal Department of Foreign Affairs and the Swiss Federal Institute of Technology in Zurich have launched the International Computation and...
News 11 jan 2023 Bachem Group secures CHF 1 billion peptide supply contract Bachem Group's recent CHF 1 billion peptide supply deal, spanning over five years will enable the company's plans to expand capacity across all i...
Actualités 11 out 2023 Lonza élargit davantage ses capacités de fabrication d’ADC à Viège Lonza amplifie sa production d’ADC via une extension importante de la capacité de bioconjugaison de son Ibex Dedicate Biopark à Viège, ce qui dev...
News 27 out 2023 Roche uses artificial intelligence for cancer diagnosis Roche is teaming up with Ibex Medical Analytics and Amazon Web Services in the field of artificial intelligence (AI). The goal is to help patholo...
News 17 out 2023 Launch of the Open Quantum Institute in Geneva The Open Quantum Institute (OQI) was officially launched on 13 October 2023. This endeavor, resulting from a collaborative effort involving the F...
News 23 nov 2023 biped.ai secures CHF 1.2 million for US expansion and European growth Lausanne-based start-up biped.ai, known for its revolutionary technology aiding the visually impaired, has successfully raised CHF 1.2 million.